-
Recursion Enters into Agreements to Acquire Cyclica and Valence
-
Recursion Reports First Quarter Financial Results
-
Recursion CEO, Chris Gibson, Named Among Most Influential People in Biopharma in 2023
-
Culmination Bio and Cofactor Genomics Leverage Largest Biobank in the U.S. for PreDAPT Precision Medicine Clinical Trial
-
Vistim Labs Closes First Round of Funding
-
Kent Savage of PhotoPharmics Featured Speaker on MedTech Innovator’s Device Talks 2023
-
Utah Business 30 Women to Watch: Meet the Leading Ladies of 2023
-
Bruce Hunter Named New Interim Chief Innovation and Economic Engagement Officer
-
CivicaRx Disrupts Prescription Medication Pricing
-
Workforce Services Highlight: Hiring Youth
-
Teva Reports First Quarter 2023 Financial Results and Reaffirms 2023 Non-GAAP Outlook
-
Foldax, Inc. Receives Full Ownership Rights to Proprietary Polymer Patent Portfolio
-
Merit Medical Reports Results for First Quarter March 31, 2023
-
Nusano Announces In-House Stable Isotope Program Led by Renowned Physicist Sarko Cherekdjian
-
Owlet Announces First Quarter 2023 Financial Results
-
Master of Business Creation (MBC) Adds New Option to Join Online Program in Fall 2023